143 related articles for article (PubMed ID: 32517588)
1.
Ge J; Jiang L; Tian Y; Zheng M; Huang M; Li J
J Int Med Res; 2020 Apr; 48(4):300060520919252. PubMed ID: 32517588
[TBL] [Abstract][Full Text] [Related]
2. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
3.
Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
5. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Dai Y; Liu Y; Tian X; Zhang X
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):101-6. PubMed ID: 25975685
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
8. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
Wang JL; Wang X; Yang D; Shi WJ
Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279
[TBL] [Abstract][Full Text] [Related]
9. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
[TBL] [Abstract][Full Text] [Related]
10. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
Hu C; Fan J; He G; Dong C; Zhou S; Zheng Y
PLoS One; 2022; 17(6):e0269166. PubMed ID: 35653344
[TBL] [Abstract][Full Text] [Related]
11. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
[TBL] [Abstract][Full Text] [Related]
13. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
14. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic score model incorporating CDGSH iron sulfur domain2 (CISD2) predicts risk of disease progression in laryngeal squamous cell carcinoma.
Yang L; Hong S; Wang Y; He Z; Liang S; Chen H; He S; Wu S; Song L; Chen Y
Oncotarget; 2016 Apr; 7(16):22720-32. PubMed ID: 27007153
[TBL] [Abstract][Full Text] [Related]
17. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.
Shen Z; Cao B; Lin L; Zhou C; Ye D; Qiu S; Li Q; Cui X
Med Sci Monit; 2017 Jul; 23():3635-3640. PubMed ID: 28743857
[TBL] [Abstract][Full Text] [Related]
19. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
[TBL] [Abstract][Full Text] [Related]
20. ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma.
Nicolau-Neto P; Peryassú BC; de Carvalho FN; Souza-Santos PT; Valverde P; Nascimento CM; Costa I; Dias FL; Pinto LFR
Head Neck; 2024 Apr; 46(4):785-796. PubMed ID: 38196304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]